TPA
Trivium Point Advisory Portfolio holdings
AUM
$921M
This Quarter Return
-2.34%
1 Year Return
+27.09%
3 Year Return
+91.38%
5 Year Return
+135.39%
10 Year Return
–
AUM
$322M
AUM Growth
+$322M
(-3.2%)
Cap. Flow
+$5.5M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
25.53%
Holding
207
New
6
Increased
103
Reduced
56
Closed
19
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$5.68M |
| 2 |
W.P. Carey
WPC
|
$1.23M |
| 3 |
First Trust Senior Loan Fund ETF
FTSL
|
$1.06M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$1.03M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$701K |
Top Sells
| 1 |
Applied Materials
AMAT
|
$1.77M |
| 2 |
Expedia Group
EXPE
|
$1.73M |
| 3 |
Charles River Laboratories
CRL
|
$795K |
| 4 |
iShares Russell 2000 ETF
IWM
|
$714K |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
$486K |
Sector Composition
| 1 | Technology | 17.3% |
| 2 | Financials | 15.09% |
| 3 | Consumer Discretionary | 11.92% |
| 4 | Healthcare | 10.61% |
| 5 | Communication Services | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Vanguard S&P 500 ETF
VOO
$726B
| $379K | 0.12% |
1,105
-5
| -0.5% | -$1.72K |
|
152
Eaton
ETN
$136B
| $377K | 0.12% |
2,647
-76
| -3% | -$10.8K |
|
153
DexCom
DXCM
$29.5B
| $374K | 0.12% |
3,931
-78
| -2% | -$7.42K |
|
154
Bristol-Myers Squibb
BMY
$96B
| $373K | 0.12% |
5,306
-276
| -5% | -$19.4K |
|
155
ServiceNow
NOW
$190B
| $370K | 0.11% |
885
+16
| +2% | +$6.69K |
|
156
PayPal
PYPL
$67.1B
| $363K | 0.11% |
3,847
+556
| +17% | +$52.5K |
|
157
Trade Desk
TTD
$26.7B
| $355K | 0.11% |
5,797
-21
| -0.4% | -$1.29K |
|
158
Target
TGT
$43.6B
| $328K | 0.1% |
2,104
-245
| -10% | -$38.2K |
|
159
Moderna
MRNA
$9.37B
| $318K | 0.1% |
+2,538
| New | +$318K |
|
160
SPDR Portfolio Emerging Markets ETF
SPEM
$13.1B
| $294K | 0.09% |
9,137
-2,896
| -24% | -$93.2K |
|
161
Vanguard Short-Term Treasury ETF
VGSH
$22.9B
| $267K | 0.08% |
4,631
+339
| +8% | +$19.5K |
|
162
Pinterest
PINS
$24.9B
| $252K | 0.08% |
+9,740
| New | +$252K |
|
163
AbbVie
ABBV
$372B
| $250K | 0.08% |
1,781
-224
| -11% | -$31.4K |
|
164
CVS Health
CVS
$92.8B
| $248K | 0.08% |
2,518
+99
| +4% | +$9.75K |
|
165
Newell Brands
NWL
$2.48B
| $246K | 0.08% |
17,074
-695
| -4% | -$10K |
|
166
Ares Management
ARES
$39.3B
| $243K | 0.08% |
3,618
-24
| -0.7% | -$1.61K |
|
167
Amgen
AMGN
$155B
| $230K | 0.07% |
995
-29
| -3% | -$6.7K |
|
168
Veru
VERU
$47.6M
| $228K | 0.07% |
20,000
| – | – |
|
|
BRSP
169
BrightSpire Capital
BRSP
$754M
| $227K | 0.07% |
34,715
| – | – |
|
170
Schwab US Mid-Cap ETF
SCHM
$12.1B
| $221K | 0.07% |
3,457
+38
| +1% | +$2.43K |
|
171
Cencora
COR
$56.5B
| $216K | 0.07% |
1,543
| – | – |
|
172
BILL Holdings
BILL
$4.72B
| $211K | 0.07% |
+1,422
| New | +$211K |
|
173
CoStar Group
CSGP
$37.9B
| $210K | 0.07% |
+2,789
| New | +$210K |
|
174
Simon Property Group
SPG
$59B
| $205K | 0.06% |
2,160
-782
| -27% | -$74.2K |
|
175
W.W. Grainger
GWW
$48.5B
| $204K | 0.06% |
+401
| New | +$204K |
|